Matches in Wikidata for { <http://www.wikidata.org/entity/Q73270531> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q73270531 description "article scientifique publié en 1997" @default.
- Q73270531 description "artikull shkencor i botuar më 01 shkurt 1997" @default.
- Q73270531 description "artículu científicu espublizáu en febreru de 1997" @default.
- Q73270531 description "im Februar 1997 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73270531 description "scientific article published on 01 February 1997" @default.
- Q73270531 description "wetenschappelijk artikel" @default.
- Q73270531 description "наукова стаття, опублікована в лютому 1997" @default.
- Q73270531 name "Nafamostat mesilate, a synthetic protease inhibitor, attenuated hypercoagulability in a canine model of hemorrhagic shock" @default.
- Q73270531 name "Nafamostat mesilate, a synthetic protease inhibitor, attenuated hypercoagulability in a canine model of hemorrhagic shock" @default.
- Q73270531 name "Nafamostat mesilate, a synthetic protease inhibitor, attenuated hypercoagulability in a canine model of hemorrhagic shock" @default.
- Q73270531 type Item @default.
- Q73270531 label "Nafamostat mesilate, a synthetic protease inhibitor, attenuated hypercoagulability in a canine model of hemorrhagic shock" @default.
- Q73270531 label "Nafamostat mesilate, a synthetic protease inhibitor, attenuated hypercoagulability in a canine model of hemorrhagic shock" @default.
- Q73270531 label "Nafamostat mesilate, a synthetic protease inhibitor, attenuated hypercoagulability in a canine model of hemorrhagic shock" @default.
- Q73270531 prefLabel "Nafamostat mesilate, a synthetic protease inhibitor, attenuated hypercoagulability in a canine model of hemorrhagic shock" @default.
- Q73270531 prefLabel "Nafamostat mesilate, a synthetic protease inhibitor, attenuated hypercoagulability in a canine model of hemorrhagic shock" @default.
- Q73270531 prefLabel "Nafamostat mesilate, a synthetic protease inhibitor, attenuated hypercoagulability in a canine model of hemorrhagic shock" @default.
- Q73270531 P1433 Q73270531-73408845-1FC1-427F-8D97-D1904A39E8AA @default.
- Q73270531 P1476 Q73270531-AA4BC24B-D116-4156-B8C3-EB0B06EC2DC8 @default.
- Q73270531 P2093 Q73270531-373780BB-95B6-4032-A58C-ADAE0E8FA766 @default.
- Q73270531 P2093 Q73270531-612F644B-0FEC-42B6-90E3-788F14805F89 @default.
- Q73270531 P2093 Q73270531-7F14429E-6E60-448D-9211-15BE7CA83BBA @default.
- Q73270531 P2093 Q73270531-B10C800F-3B12-4CEF-8399-C63851E39BDE @default.
- Q73270531 P304 Q73270531-E1FCB263-53F8-4BBA-BBD2-04AE9E1F1D52 @default.
- Q73270531 P31 Q73270531-FB84485F-BC28-474C-8DA2-6475F9865BBA @default.
- Q73270531 P356 Q73270531-8A914372-DD42-4CC1-B8A1-65ACEC14D512 @default.
- Q73270531 P433 Q73270531-EEE3F8D9-FEE4-433B-BACE-BFEEFA2C2A6B @default.
- Q73270531 P478 Q73270531-9568FD6E-73C2-41E5-B32C-C8E46550E087 @default.
- Q73270531 P577 Q73270531-D5A41AF1-6D8A-4688-850F-9D3D7E96825C @default.
- Q73270531 P698 Q73270531-980A730B-7F76-486D-B800-847A38733264 @default.
- Q73270531 P921 Q73270531-5020B8C2-E39B-4A6D-9376-F2732512B808 @default.
- Q73270531 P921 Q73270531-630A8C46-760C-46AE-96ED-459B21B03A08 @default.
- Q73270531 P356 JNMS1923.64.9 @default.
- Q73270531 P698 9119959 @default.
- Q73270531 P1433 Q117866220 @default.
- Q73270531 P1476 "Nafamostat mesilate, a synthetic protease inhibitor, attenuated hypercoagulability in a canine model of hemorrhagic shock" @default.
- Q73270531 P2093 "K Kato" @default.
- Q73270531 P2093 "K Shichinohe" @default.
- Q73270531 P2093 "M Shimizu-Suganuma" @default.
- Q73270531 P2093 "Y Koido" @default.
- Q73270531 P304 "9-15" @default.
- Q73270531 P31 Q13442814 @default.
- Q73270531 P356 "10.1272/JNMS1923.64.9" @default.
- Q73270531 P433 "1" @default.
- Q73270531 P478 "64" @default.
- Q73270531 P577 "1997-02-01T00:00:00Z" @default.
- Q73270531 P698 "9119959" @default.
- Q73270531 P921 Q1570013 @default.
- Q73270531 P921 Q2964243 @default.